Several GWAS have demonstrated that genetic variants in CHRNA5 and CHRNA3, located at the 15q25.1 lung cancer susceptibility locus [20], [21], influence the risk of developing lung cancer in European and US populations [5], [21]. This evidence concerns the gene CHRNA3 and lung carcinoma.